Click for best price
Tuberculosis Vaccine Drug Market Size, Share 2024
The global Tuberculosis Vaccine Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Immune Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis Vaccine Drug include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine Drug. This report contains market size and forecasts of Tuberculosis Vaccine Drug in global, including the following market information:
Global Tuberculosis Vaccine Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Tuberculosis Vaccine Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Tuberculosis Vaccine Drug companies in 2023 (%)
We has surveyed the Tuberculosis Vaccine Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Vaccine Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Tuberculosis Vaccine Drug Market Segment Percentages, by Type, 2023 (%)
Immune Vaccine
Therapy Vaccine
Global Tuberculosis Vaccine Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Tuberculosis Vaccine Drug Market Segment Percentages, by Application, 2023 (%)
Self-Procurement
UNICEF
Other
Global Tuberculosis Vaccine Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Tuberculosis Vaccine Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis Vaccine Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Tuberculosis Vaccine Drug revenues share in global market, 2023 (%)
Key companies Tuberculosis Vaccine Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Tuberculosis Vaccine Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tuberculosis Vaccine Drug, market overview.
Chapter 2: Global Tuberculosis Vaccine Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Tuberculosis Vaccine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tuberculosis Vaccine Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tuberculosis Vaccine Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Tuberculosis Vaccine Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Vaccine Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Vaccine Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Vaccine Drug Overall Market Size
2.1 Global Tuberculosis Vaccine Drug Market Size: 2023 VS 2030
2.2 Global Tuberculosis Vaccine Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Tuberculosis Vaccine Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Tuberculosis Vaccine Drug Players in Global Market
3.2 Top Global Tuberculosis Vaccine Drug Companies Ranked by Revenue
3.3 Global Tuberculosis Vaccine Drug Revenue by Companies
3.4 Global Tuberculosis Vaccine Drug Sales by Companies
3.5 Global Tuberculosis Vaccine Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Tuberculosis Vaccine Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Tuberculosis Vaccine Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Vaccine Drug Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Vaccine Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Vaccine Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Vaccine Drug Market Size Markets, 2023 & 2030
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type - Global Tuberculosis Vaccine Drug Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Vaccine Drug Revenue, 2019-2024
4.2.2 By Type - Global Tuberculosis Vaccine Drug Revenue, 2025-2030
4.2.3 By Type - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Tuberculosis Vaccine Drug Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Vaccine Drug Sales, 2019-2024
4.3.2 By Type - Global Tuberculosis Vaccine Drug Sales, 2025-2030
4.3.3 By Type - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
4.4 By Type - Global Tuberculosis Vaccine Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Vaccine Drug Market Size, 2023 & 2030
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Other
5.2 By Application - Global Tuberculosis Vaccine Drug Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Vaccine Drug Revenue, 2019-2024
5.2.2 By Application - Global Tuberculosis Vaccine Drug Revenue, 2025-2030
5.2.3 By Application - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Tuberculosis Vaccine Drug Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Vaccine Drug Sales, 2019-2024
5.3.2 By Application - Global Tuberculosis Vaccine Drug Sales, 2025-2030
5.3.3 By Application - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
5.4 By Application - Global Tuberculosis Vaccine Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Tuberculosis Vaccine Drug Market Size, 2023 & 2030
6.2 By Region - Global Tuberculosis Vaccine Drug Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Vaccine Drug Revenue, 2019-2024
6.2.2 By Region - Global Tuberculosis Vaccine Drug Revenue, 2025-2030
6.2.3 By Region - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Tuberculosis Vaccine Drug Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Vaccine Drug Sales, 2019-2024
6.3.2 By Region - Global Tuberculosis Vaccine Drug Sales, 2025-2030
6.3.3 By Region - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Tuberculosis Vaccine Drug Revenue, 2019-2030
6.4.2 By Country - North America Tuberculosis Vaccine Drug Sales, 2019-2030
6.4.3 US Tuberculosis Vaccine Drug Market Size, 2019-2030
6.4.4 Canada Tuberculosis Vaccine Drug Market Size, 2019-2030
6.4.5 Mexico Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Vaccine Drug Revenue, 2019-2030
6.5.2 By Country - Europe Tuberculosis Vaccine Drug Sales, 2019-2030
6.5.3 Germany Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.4 France Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.5 U.K. Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.6 Italy Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.7 Russia Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.8 Nordic Countries Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.9 Benelux Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Vaccine Drug Revenue, 2019-2030
6.6.2 By Region - Asia Tuberculosis Vaccine Drug Sales, 2019-2030
6.6.3 China Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.4 Japan Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.5 South Korea Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.6 Southeast Asia Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.7 India Tuberculosis Vaccine Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Tuberculosis Vaccine Drug Revenue, 2019-2030
6.7.2 By Country - South America Tuberculosis Vaccine Drug Sales, 2019-2030
6.7.3 Brazil Tuberculosis Vaccine Drug Market Size, 2019-2030
6.7.4 Argentina Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Vaccine Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Tuberculosis Vaccine Drug Sales, 2019-2030
6.8.3 Turkey Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8.4 Israel Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8.6 UAE Tuberculosis Vaccine Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Vaccine Drug Major Product Offerings
7.1.4 Merck Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Company Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Major Product Offerings
7.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.2.5 Japan BCG Lab Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccine Drug Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 AJ Vaccines
7.4.1 AJ Vaccines Company Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Vaccine Drug Major Product Offerings
7.4.4 AJ Vaccines Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.4.5 AJ Vaccines Key News & Latest Developments
7.5 BioFarma
7.5.1 BioFarma Company Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Vaccine Drug Major Product Offerings
7.5.4 BioFarma Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.5.5 BioFarma Key News & Latest Developments
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Company Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Major Product Offerings
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.6.5 GreenSignal Bio Pharma Key News & Latest Developments
7.7 China National Biotec
7.7.1 China National Biotec Company Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Vaccine Drug Major Product Offerings
7.7.4 China National Biotec Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.7.5 China National Biotec Key News & Latest Developments
7.8 Biomed Lublin
7.8.1 Biomed Lublin Company Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Vaccine Drug Major Product Offerings
7.8.4 Biomed Lublin Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.8.5 Biomed Lublin Key News & Latest Developments
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Company Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Major Product Offerings
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.9.5 Taj Pharmaceuticals Key News & Latest Developments
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Company Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Major Product Offerings
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.10.5 Ataulpho de Paiva Key News & Latest Developments
7.11 IVAC
7.11.1 IVAC Company Summary
7.11.2 IVAC Tuberculosis Vaccine Drug Business Overview
7.11.3 IVAC Tuberculosis Vaccine Drug Major Product Offerings
7.11.4 IVAC Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.11.5 IVAC Key News & Latest Developments
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Company Summary
7.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Business Overview
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.12.5 Queen Saovabha Mem. Inst Key News & Latest Developments
7.13 Microgen
7.13.1 Microgen Company Summary
7.13.2 Microgen Tuberculosis Vaccine Drug Business Overview
7.13.3 Microgen Tuberculosis Vaccine Drug Major Product Offerings
7.13.4 Microgen Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.13.5 Microgen Key News & Latest Developments
8 Global Tuberculosis Vaccine Drug Production Capacity, Analysis
8.1 Global Tuberculosis Vaccine Drug Production Capacity, 2019-2030
8.2 Tuberculosis Vaccine Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Vaccine Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Vaccine Drug Supply Chain Analysis
10.1 Tuberculosis Vaccine Drug Industry Value Chain
10.2 Tuberculosis Vaccine Drug Upstream Market
10.3 Tuberculosis Vaccine Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Vaccine Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Tuberculosis Vaccine Drug in Global Market
Table 2. Top Tuberculosis Vaccine Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Tuberculosis Vaccine Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Tuberculosis Vaccine Drug Revenue Share by Companies, 2019-2024
Table 5. Global Tuberculosis Vaccine Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global Tuberculosis Vaccine Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Tuberculosis Vaccine Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Tuberculosis Vaccine Drug Product Type
Table 9. List of Global Tier 1 Tuberculosis Vaccine Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Vaccine Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Tuberculosis Vaccine Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Tuberculosis Vaccine Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Tuberculosis Vaccine Drug Sales (K Units), 2019-2024
Table 15. By Type - Global Tuberculosis Vaccine Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Tuberculosis Vaccine Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Tuberculosis Vaccine Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Tuberculosis Vaccine Drug Sales (K Units), 2019-2024
Table 20. By Application - Global Tuberculosis Vaccine Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Tuberculosis Vaccine Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Tuberculosis Vaccine Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Tuberculosis Vaccine Drug Sales (K Units), 2019-2024
Table 25. By Region - Global Tuberculosis Vaccine Drug Sales (K Units), 2025-2030
Table 26. By Country - North America Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Tuberculosis Vaccine Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America Tuberculosis Vaccine Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Tuberculosis Vaccine Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe Tuberculosis Vaccine Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Tuberculosis Vaccine Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia Tuberculosis Vaccine Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Tuberculosis Vaccine Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America Tuberculosis Vaccine Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Tuberculosis Vaccine Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Tuberculosis Vaccine Drug Sales, (K Units), 2025-2030
Table 46. Merck Company Summary
Table 47. Merck Tuberculosis Vaccine Drug Product Offerings
Table 48. Merck Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. Japan BCG Lab Company Summary
Table 51. Japan BCG Lab Tuberculosis Vaccine Drug Product Offerings
Table 52. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Japan BCG Lab Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India Tuberculosis Vaccine Drug Product Offerings
Table 56. Serum Institute of India Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. AJ Vaccines Company Summary
Table 59. AJ Vaccines Tuberculosis Vaccine Drug Product Offerings
Table 60. AJ Vaccines Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. AJ Vaccines Key News & Latest Developments
Table 62. BioFarma Company Summary
Table 63. BioFarma Tuberculosis Vaccine Drug Product Offerings
Table 64. BioFarma Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. BioFarma Key News & Latest Developments
Table 66. GreenSignal Bio Pharma Company Summary
Table 67. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Offerings
Table 68. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. GreenSignal Bio Pharma Key News & Latest Developments
Table 70. China National Biotec Company Summary
Table 71. China National Biotec Tuberculosis Vaccine Drug Product Offerings
Table 72. China National Biotec Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. China National Biotec Key News & Latest Developments
Table 74. Biomed Lublin Company Summary
Table 75. Biomed Lublin Tuberculosis Vaccine Drug Product Offerings
Table 76. Biomed Lublin Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Biomed Lublin Key News & Latest Developments
Table 78. Taj Pharmaceuticals Company Summary
Table 79. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Offerings
Table 80. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Taj Pharmaceuticals Key News & Latest Developments
Table 82. Ataulpho de Paiva Company Summary
Table 83. Ataulpho de Paiva Tuberculosis Vaccine Drug Product Offerings
Table 84. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Ataulpho de Paiva Key News & Latest Developments
Table 86. IVAC Company Summary
Table 87. IVAC Tuberculosis Vaccine Drug Product Offerings
Table 88. IVAC Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. IVAC Key News & Latest Developments
Table 90. Queen Saovabha Mem. Inst Company Summary
Table 91. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Offerings
Table 92. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Queen Saovabha Mem. Inst Key News & Latest Developments
Table 94. Microgen Company Summary
Table 95. Microgen Tuberculosis Vaccine Drug Product Offerings
Table 96. Microgen Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Microgen Key News & Latest Developments
Table 98. Tuberculosis Vaccine Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Tuberculosis Vaccine Drug Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Tuberculosis Vaccine Drug Production by Region, 2019-2024 (K Units)
Table 101. Global Tuberculosis Vaccine Drug Production by Region, 2025-2030 (K Units)
Table 102. Tuberculosis Vaccine Drug Market Opportunities & Trends in Global Market
Table 103. Tuberculosis Vaccine Drug Market Drivers in Global Market
Table 104. Tuberculosis Vaccine Drug Market Restraints in Global Market
Table 105. Tuberculosis Vaccine Drug Raw Materials
Table 106. Tuberculosis Vaccine Drug Raw Materials Suppliers in Global Market
Table 107. Typical Tuberculosis Vaccine Drug Downstream
Table 108. Tuberculosis Vaccine Drug Downstream Clients in Global Market
Table 109. Tuberculosis Vaccine Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tuberculosis Vaccine Drug Segment by Type in 2023
Figure 2. Tuberculosis Vaccine Drug Segment by Application in 2023
Figure 3. Global Tuberculosis Vaccine Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Vaccine Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Tuberculosis Vaccine Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Tuberculosis Vaccine Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tuberculosis Vaccine Drug Revenue in 2023
Figure 9. By Type - Global Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Tuberculosis Vaccine Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Tuberculosis Vaccine Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 23. US Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 28. Germany Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 37. China Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 44. Brazil Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
Figure 48. Turkey Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Tuberculosis Vaccine Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Tuberculosis Vaccine Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Tuberculosis Vaccine Drug by Region, 2023 VS 2030
Figure 54. Tuberculosis Vaccine Drug Industry Value Chain
Figure 55. Marketing Channels
